✦ LIBER ✦

Valsartan: Long Term Efficacy and Tolerability Compared to Lisinopril in Elderly Patients with Essential Hypertension

✍ Scribed by Ad, Bremner; M, Baur; P, Oddou-Stock; F, Bodin

Book ID: 126599347
Publisher: Informa plc
Year: 1997
Tongue: English
Weight: 907 KB
Volume: 19
Category: Article
ISSN: 1064-1963
DOI: 10.3109/10641969709083217

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

D019 Long term efficacy and tolerability

D019 Long term efficacy and tolerability of diovan® in elderly hypertensive patients compared with lisinopril

✍ S. Meilenbrock; P. Oddou-Stock; A. Bremner 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

Efficacy and Tolerability of Valsartan C

Efficacy and Tolerability of Valsartan Compared with Lisinopril in Patients with Hypertension and Renal Insufficiency

✍ Dr Norberto Perico, D. Spormann, E. Peruzzi, F. Bodin, Antoine Sioufi, F. Bertoc 📂 Article 📅 1997 🏛 Springer International Publishing AG 🌐 English ⚖ 823 KB

Long-term efficacy, safety, and tolerabi

Long-term efficacy, safety, and tolerability of valsartan and hydrochlorothiazide in patients with essential hypertension

✍ Steven G. Chrysant; Duane G. Womboldt; Nancy Feliciano; Hongjie Zheng 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 794 KB

Efficacy, safety, and tolerability of va

Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension

✍ Wen-Ter Lai; Jeong-Euy Park; Neelesh Dongre; Jackson Wang 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 605 KB

Long term efficacy and tolerability of i

Long term efficacy and tolerability of irbesartan in elderly hypertensive patients with renal impairment

✍ Maria Leonarda M.L. De Rosa; Piercarmine P. Cardace; Massimiliano M. Rossi; Ales 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 43 KB

Valsartan, a new angiotensin II antagoni

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

✍ Black, H R; Graff, A; Shute, D; Stoltz, R; Ruff, D; Levine, J; Shi, Y; Mallows, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 272 KB